Association between ultra-processed food consumption and inflammation: insights from the STANISLAS cohort
- PMID: 39960649
- DOI: 10.1007/s00394-025-03607-y
Association between ultra-processed food consumption and inflammation: insights from the STANISLAS cohort
Abstract
Purpose: High consumption of ultra-processed food (UPF) is associated with an increased risk of developing chronic diseases. Inflammation may be one of the underlying mechanisms behind this association. However, only a limited number of studies have investigated the association between UPF consumption and a few selected inflammation biomarkers, yielding inconsistent results. This study aimed to assess the cross-sectional association between UPF consumption (as a whole and 10 sub-categories), and 78 circulating proteins related to inflammation.
Methods: The present study included 1594 adult participants from the STANISLAS cohort. UPF consumption was estimated using the NOVA classification, and linear regression models were used to assess their association with circulating proteins.
Results: UPFs accounted for 28% of the total energy intake and 5.7 servings on average per day. In the unadjusted model, 15 circulating proteins had a significant association with UPF consumption. After adjustment, only (FGF-19) was significantly associated with UPF consumption (β = - 0.02[- 0.03; - 0.003]).
Conclusion: UPF consumption was negatively associated with Fibroblast Growth Factor 19 (FGF-19) serum levels. When considering UPF sub-categories, no circulating proteins were associated with dairy products and dairy desserts. Of note, circulating proteins were differentially associated depending on the sub-category of UPF. Further studies are needed to better understand the link between UPF and inflammation.
Keywords: Circulating protein; Fibroblast growth factor 19; Inflammation; NOVA; Olink; Ultra-processed food.
© 2025. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: NG has received honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, Novartis, Novo Nordisk, Roche Diagnostics, NP Medical, and Echosens. The other co-authors declare that they have no conflict of interest.
References
-
- Julia C, Martinez L, Allès B et al (2018) Contribution of ultra-processed foods in the diet of adults from the French NutriNet-Santé study. Public Health Nutr 21:27–37. https://doi.org/10.1017/S1368980017001367 - DOI - PubMed
-
- Monteiro CA, Cannon G, Moubarac J-C et al (2018) The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing. Public Health Nutr 21:5–17. https://doi.org/10.1017/S1368980017000234 - DOI - PubMed
-
- Monteiro CA, Cannon G, Levy R et al (2016) NOVA. The star shines bright. World Nutr. 7:28–38
-
- Monteiro CA, Cannon G, Levy RB et al (2019) Ultra-processed foods: what they are and how to identify them. Public Health Nutr 22:936–941. https://doi.org/10.1017/S1368980018003762 - DOI - PubMed - PMC
-
- Fardet A, Rock E (2022) Chronic diseases are first associated with the degradation and artificialization of food matrices rather than with food composition: calorie quality matters more than calorie quantity. Eur J Nutr 61:2239–2253. https://doi.org/10.1007/s00394-021-02786-8 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources